Assessment of clinical and laboratory presentations of familial hemophagocytic lymphohistiocytosis patients with homozygous W374X mutation

Simple item page
dc.contributor.authorBalta, Günay
dc.contributor.authorOkur, Hamza
dc.contributor.authorÜnal, Şule
dc.contributor.authorYaralı, Neşe
dc.contributor.authorÜnal, Selma
dc.contributor.authorTürker, Meral
dc.contributor.authorGüler, Elif
dc.contributor.authorErtem, Mehmet
dc.contributor.authorAlbayrak, Meryem
dc.contributor.authorPatıroğlu, Türkan
dc.contributor.authorGürgey, Aytemiz
dc.contributor.buuauthorGüneş, Adalet Meral
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.scopusid24072843300tr_TR
dc.date.accessioned2022-09-02T10:50:40Z
dc.date.available2022-09-02T10:50:40Z
dc.date.issued2010-08
dc.description.abstractHomozygous W374X mutation was identified in unrelated 13 patients (6M/7F) from consanguineous families, 62% of which had history of deceased sibling. Haplotype analysis provided evidence for the probable existence of a founder effect. Age at disease onset ranged from 1 day to 5.5 months (median 2 months). Hepatic dysfunction was observed in 69%, ascite 62%, hypertriglyceridemia 77%, each hyperferritinemia and hypofibrinogenemia 85%, CNS involvement 46% of patients while birth weights were in normal range. Those with very high ferritin (>20,000 ng/ml) had extremely low fibrinogen levels. Two-thirds of patients receiving HLH protocol died within 20 days of therapy.en_US
dc.description.sponsorshipTurkish Academy of Sciences European Commission (TUBA)en_US
dc.identifier.citationBalta, G. vd. (2010). "Assessment of clinical and laboratory presentations of familial hemophagocytic lymphohistiocytosis patients with homozygous W374X mutation". Leukemia Research, 34(8), 1012-1017.en_US
dc.identifier.endpage1017tr_TR
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.issue8tr_TR
dc.identifier.pubmed20197201tr_TR
dc.identifier.scopus2-s2.0-77953614261tr_TR
dc.identifier.startpage1012tr_TR
dc.identifier.urihttps://doi.org/10.1016/j.leukres.2010.02.002
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0145212610000809
dc.identifier.urihttp://hdl.handle.net/11452/28438
dc.identifier.volume34tr_TR
dc.identifier.wos000278601600012tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevieren_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalLeukemia Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.relation.tubitak105S386-SBAG 3193tr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFamilial hemophagocytic lymphohistiocytosisen_US
dc.subjectFHLen_US
dc.subjectPerforin geneen_US
dc.subjectW374X mutationen_US
dc.subjectClinical implicationsen_US
dc.subjectGenotype-phenotypeen_US
dc.subjectFounder effecten_US
dc.subjectTurkish childrenen_US
dc.subjectOncologyen_US
dc.subjectHematologyen_US
dc.subject.emtreeAlanine aminotransferaseen_US
dc.subject.emtreeAlbuminen_US
dc.subject.emtreeAntibiotic agenten_US
dc.subject.emtreeAspartate aminotransferaseen_US
dc.subject.emtreeBilirubinen_US
dc.subject.emtreeCyclosporinen_US
dc.subject.emtreeD dimeren_US
dc.subject.emtreeFerritinen_US
dc.subject.emtreeFibrinogenen_US
dc.subject.emtreeImmunoglobulinen_US
dc.subject.emtreePrednisoloneen_US
dc.subject.emtreeSodiumen_US
dc.subject.emtreeSteroiden_US
dc.subject.emtreeTriacylglycerolen_US
dc.subject.emtreeUreaen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBirth weighten_US
dc.subject.emtreeCentral nervous systemen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeConsanguinityen_US
dc.subject.emtreeErythrocyte transfusionen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFerritin blood levelen_US
dc.subject.emtreeFfibrinogen blood levelen_US
dc.subject.emtreeGene mutationen_US
dc.subject.emtreeGenotype phenotype correlationen_US
dc.subject.emtreeHaplotypeen_US
dc.subject.emtreeHemophagocytic lymphohistiocytosisen_US
dc.subject.emtreeHomozygosityen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHyperferritinemiaen_US
dc.subject.emtreeHypertriglyceridemiaen_US
dc.subject.emtreeHypofibrinogenemiaen_US
dc.subject.emtreeInfanten_US
dc.subject.emtreeLiver dysfunctionen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreePancytopeniaen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeSepsisen_US
dc.subject.emtreeThrombocyte transfusionen_US
dc.subject.meshConsanguinityen_US
dc.subject.meshFemaleen_US
dc.subject.meshFerritinsen_US
dc.subject.meshFibrinogenen_US
dc.subject.meshHomozygoteen_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.subject.meshInfant, newbornen_US
dc.subject.meshLymphohistiocytosis, hemophagocyticen_US
dc.subject.meshMaleen_US
dc.subject.meshMutationen_US
dc.subject.meshPrognosisen_US
dc.subject.scopusHemophagocytic Lymphohistiocytosis; Macrophage Activation Syndrome; Juvenile Arthritisen_US
dc.subject.wosOncologyen_US
dc.subject.wosHematologyen_US
dc.titleAssessment of clinical and laboratory presentations of familial hemophagocytic lymphohistiocytosis patients with homozygous W374X mutationen_US
dc.typeArticle
dc.wos.quartileQ3 (Hematology)en_US
dc.wos.quartileQ2 (Oncology)en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
Scopus